Literature DB >> 8102368

The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer.

K Padmanabhan1, K P Padmanabhan, J D Ferrara, J E Sadler, A Tulinsky.   

Abstract

The structure of a complex between human alpha-thrombin and a GGTTGGTGTGGTTGG 15-nucleotide consensus sequence has been solved by x-ray crystallography and refined at 2.9-A resolution to an R value of 0.159. As in solution, in the complex the single-stranded DNA folds into a structure with two G-quartets. The DNA is sandwiched between two different positively charged regions of two symmetry-related thrombin molecules in the crystal structure making ionic and hydrophobic interactions. One region is the fibrinogen recognition exosite and the other, the putative heparin binding site. The lack of inhibition of fibrinogen clotting and platelet activation by the DNA 15-mer with the Arg75-->Glu mutant of thrombin is consistent with the several salt bridges of the DNA in the fibrinogen exosite. The association of DNA with the heparin site of a neighboring molecule appears to simply compensate residual charge. Differences in the 15-mer loop conformations between the complex and NMR solution structures can be attributed to conformational changes upon thrombin binding. Although G-quadruplexes are favored in the presence of monovalent cations, there is no evidence of the latter in the thrombin complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102368     DOI: 10.2210/pdb1hut/pdb

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  Crystallization and preliminary X-ray analysis of the complex of human alpha-thrombin with a modified thrombin-binding aptamer.

Authors:  Irene Russo Krauss; Antonello Merlino; Antonio Randazzo; Lelio Mazzarella; Filomena Sica
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-29

2.  Mass spectrometric studies of alkali metal ion binding on thrombin-binding aptamer DNA.

Authors:  Eun Sun Hong; Hye-Joo Yoon; Byungjoo Kim; Yong-Hyeon Yim; Hun-Young So; Seung Koo Shin
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-02       Impact factor: 3.109

3.  Single-stranded DNA oligoaptamers: molecular recognition and LPS antagonism are length- and secondary structure-dependent.

Authors:  J L Ding; S T Gan; B Ho
Journal:  J Innate Immun       Date:  2008-07-12       Impact factor: 7.349

Review 4.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

5.  The effect on quadruplex stability of North-nucleoside derivatives in the loops of the thrombin-binding aptamer.

Authors:  Anna Aviñó; Stefania Mazzini; Ruben Ferreira; Raimundo Gargallo; Victor E Marquez; Ramon Eritja
Journal:  Bioorg Med Chem       Date:  2012-06-09       Impact factor: 3.641

Review 6.  Modulation of the Coagulation Cascade Using Aptamers.

Authors:  Rebecca S Woodruff; Bruce A Sullenger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-27       Impact factor: 8.311

7.  Kinetics of protein-release by an aptamer-based DNA nanodevice.

Authors:  A Reuter; W U Dittmer; F C Simmel
Journal:  Eur Phys J E Soft Matter       Date:  2007-02-16       Impact factor: 1.890

8.  Stability and binding properties of a modified thrombin binding aptamer.

Authors:  Bruno Pagano; Luigi Martino; Antonio Randazzo; Concetta Giancola
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

9.  Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer.

Authors:  Yee-Wai Cheung; Jane Kwok; Alan W L Law; Rory M Watt; Masayo Kotaka; Julian A Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.